More Downside For Medtronic Stock?
1. Medtronic's stock fell 50% from 2021 peak to 2023. 2. Despite $33.2 billion revenue, cash flow concerns persist. 3. Historical downturns show MDT performs worse than S&P 500. 4. Recent economic uncertainties may hinder MDT's market recovery. 5. MDT's trailing P/E remains high despite slowing growth.